Compare Aurora Cannabis Inc (ACB) vs ARK Genomic Revolution ETF (ARKG) Price & Performance

Aurora Cannabis IncTrade

ARK Genomic Revolution ETFTrade

Price performance (Past 24H)

Key statistics

Aurora Cannabis Inc vs ARK Genomic Revolution ETF — how do they compare? Aurora Cannabis Inc trades at $3.4 (market cap $223.59M), while ARK Genomic Revolution ETF trades at $44.7. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.

	ACB	ARKG
Market Cap	$223.59M	—
Sector	Health	Sector/Thematic
52-Week High	$6.23	$44.55
52-Week Low	$2.58	$24.02
Enterprise Value	$168.09M	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ACB

Aurora Cannabis reviews unsolicited $4/share takeover bid from Curaleaf, no decision yet.PRNewsWire · 21 hours agoNeutral Curaleaf launches hostile bid to acquire Aurora Cannabis at $4 per share, offering shares plus cash.Proactive Investors · 21 hours agoBullish Curaleaf offers to buy Aurora Cannabis with a 45% premium, aiming to create a leading global cannabis platform.PRNewsWire · 1 day agoBullish View details →

ARKG

View details →

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.